Connealy Pamela Ann - Insider Non-Derivative Transactions at Pyxis Oncology, Inc. (PYXS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 26, 2024, Connealy Pamela Ann's relationship to Pyxis Oncology, Inc. (PYXS) is Officer (CFO & COO), and currently has 1,199,143 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PYXS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Connealy Pamela Ann - Insider Non-Derivative Transactions of PYXS Common Stock

Connealy Pamela Ann - Insider Non-Derivative Transactions at PYXS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 27, 2024	P -- (Common Stock)	5450	2	1115743
Nov 27, 2024	P -- (Common Stock)	83400	1.96	1199143
Mar 27, 2024	Acquisition -- (Common Stock)	328710	0	1110293
Nov 30, 2023	F -- (Common Stock)	36949	1.4	781583
Sep 29, 2023	P -- (Common Stock)	8000	1.87	818532
Sep 28, 2023	P -- (Common Stock)	6426	1.85	810532
Sep 26, 2023	P -- (Common Stock)	12000	1.67	804106
Sep 23, 2023	P -- (Common Stock)	5000	1.74	792106
Sep 8, 2023	Acquisition -- (Common Stock)	187793	0	782106